Terns Pharmaceuticals, Inc. short interest in 2021
In 2021, Terns Pharmaceuticals, Inc.'s disclosed short interest ran from 4.44% of shares outstanding on 14 May 2021 to 2.32% on 31 Dec 2021, a change of -2.12 percentage points. The year's high was 4.44% on 14 May 2021 and its low 2.32% on 31 Dec 2021, averaging 2.92% across 16 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 32.85 days on 28 May 2021. Full history: Terns Pharmaceuticals, Inc..
Cite this page
By year: 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2021 in figures
- Start of year
- 4.44% (14 May 2021)
- End of year
- 2.32% (31 Dec 2021)
- Change
- -2.12 pp
- High
- 4.44% (14 May 2021)
- Low
- 2.32% (31 Dec 2021)
- Average
- 2.92%
- Highest days to cover
- 32.85 (28 May 2021)
- SEC filings marked
- 8
Every report in 2021
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 14 May 2021 | 4.44% | 27.89 | 10-K filed, results (8-K), results (8-K), 10-Q filed |
| 28 May 2021 | 4.44% | 32.85 | |
| 15 Jun 2021 | 4.32% | 13.58 | |
| 30 Jun 2021 | 2.46% | 4.32 | |
| 15 Jul 2021 | 2.46% | 12.15 | |
| 30 Jul 2021 | 2.58% | 14.42 | |
| 13 Aug 2021 | 2.53% | 8.13 | |
| 31 Aug 2021 | 2.68% | 8.98 | 10-Q filed, results (8-K) |
| 15 Sep 2021 | 2.74% | 14.00 | |
| 30 Sep 2021 | 2.79% | 6.58 | |
| 15 Oct 2021 | 2.82% | 18.64 | |
| 29 Oct 2021 | 2.72% | 12.60 | |
| 15 Nov 2021 | 2.56% | 10.73 | 10-Q filed, results (8-K) |
| 30 Nov 2021 | 2.57% | 14.11 | |
| 15 Dec 2021 | 2.36% | 6.71 | |
| 31 Dec 2021 | 2.32% | 6.04 |
See also: Terns Pharmaceuticals, Inc.'s full history · most shorted US stocks of 2021 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.